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Abstract
Transcription elongation by RNA polymerase II was often considered an invariant non-regulated process. However, genome-
wide studies have shown that transcriptional pausing during elongation is a frequent phenomenon in tightly-regulated
metazoan genes. Using a combination of ChIP-on-chip and genomic run-on approaches, we found that the proportion of
transcriptionally active RNA polymerase II (active versus total) present throughout the yeast genome is characteristic of
some functional gene classes, like those related to ribosomes and mitochondria. This proportion also responds to regulatory
stimuli mediated by protein kinase A and, in relation to cytosolic ribosomal-protein genes, it is mediated by the silencing
domain of Rap1. We found that this inactive form of RNA polymerase II, which accumulates along the full length of
ribosomal protein genes, is phosphorylated in the Ser5 residue of the CTD, but is hypophosphorylated in Ser2. Using the
same experimental approach, we show that the in vivo–depletion of FACT, a chromatin-related elongation factor, also
produces a regulon-specific effect on the expression of the yeast genome. This work demonstrates that the regulation of
transcription elongation is a widespread, gene class–dependent phenomenon that also affects housekeeping genes.
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Introduction
It is well known that RNA pol II accumulates under repressive
conditions on some tightly regulated genes of higher eukaryotes,
like human c-Myc [1] and Drosophila hsp70 [2]. RNA pol II pausing
is in fact a frequent situation since a significant proportion of
metazoan genes exhibits paused polymerases at promoter-
proximal sites [3–8]. Although pauses and arrests during
transcription elongation seem to be also common phenomena
further downstream [9].
In yeast, almost 2500 repressed genes show poised RNA pol II
in the stationary phase [10] but only a few, like CYC1 and those
encoding NTP-biosynthetic enzymes, display an accumulation of
RNA pol II at their 59 region under repressive conditions in
exponential growing cells [11,12]. For NTP genes, transcription
regulation works at the level of initiation through an attenuation
mechanism [12,13]. It is not clear whether the accumulation of
RNA pol II at the 59 end in the other cases responds to a pausing
phenomenon. In any case, RNA pol II pausing at promoter-
proximal sites is not a frequent phenomenon in exponentially
growing yeast [14] which has been proposed to reflect the different
chromatin organization of the transcription start sites in yeast
compared to metazoa [15].
In the last 20 years, biochemical and genetic analyses have
revealed a numerous set of factors playing auxiliary roles in RNA
Polymerase II (RNA pol II)-dependent transcription elongation
[16]. The textbook view of transcriptional machinery is a uniform
set of players that all genes require equally. However, it is already
well known that the diversity in core promoter elements
throughout the genome reflects certain gene-specific roles of the
general transcription factors involved in the pre-initiation complex
(PIC) assembly. For instance, yeast TATA box-containing genes
are highly regulated and preferentially utilize SAGA rather than
TFIID if compared to TATA-less promoters [17]. According to
such differences, a TBP regulatory network to explain gene-
specific differences in the PIC assembly has been proposed [18].
Similarly, several examples of gene-specific roles of elongation
factors have been described. Mutations affecting the integrity of
the yeast THO complex, involved in transcription elongation and
mRNP biogenesis, decrease the expression levels of long
transcription units, but do not significantly influence the mRNA
levels of the shorter ones driven by the same promoter [19–21].
TFIIS, an elongation factor that is dispensable for the expression
of most yeast genes, is absolutely required for the activation of
IMD2 in response to NTP depletion [22]. Mammalian splicing
factor SC35 also plays a gene-specific role in transcription
elongation since its depletion produces an accumulation of inactive
RNA pol II on several, but not all, active transcription units [23].
The transcription of the p53-dependent gene p21 does not
require the phosphorylation of the carboxy-terminal domain of
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(Ser2). This indicates that the requirement of P-TEFb for
transcription elongation is also gene-specific [24]. The chromatin
factor FACT, involved in chromatin remodeling and reassembly
during transcription elongation [25,26], is also dispensable for the
expression of p21 [24]. Likewise, the expression of the yeast CUP1
gene, which can be transcribed by a mutant version of RNA Pol II
lacking the CTD [27], is not affected by FACT depletion [28].
Furthermore by comparing five genes under the control of the
same promoter, we have previously shown that FACT is not
equally required by all the genes during transcription, and that this
differential requirement is related to the chromatin configuration
of the transcribed region [28].
In this work, we investigated the distribution of actively
elongating and total RNA pol II by means of a new
methodological approach that combines genomic run-on (GRO)
and ChIP-on-chip. We detected significant gene-specific differ-
ences in the proportion of active RNA pol II present in the
transcribed regions. The effect of FACT depletion was also
differential for some gene functional categories such us those
encoding mitochondrial proteins, or housekeeping genes encoding
cytosolic ribosomal proteins and factors involved in ribosome
biogenesis. We found that the transcription elongation of
ribosome-related genes responds to regulatory stimuli mediated
by the protein kinase A pathway, and by the Rap1 transcription
factor for those genes that encode structural ribosomal proteins.
We also found that an inactive form of RNA polymerase II, which
is phosphorylated in the Ser5 residue of the CTD but is
hypophosphorylated in Ser2, accumulates along the full length
of these genes, during standard growing conditions.
Results
Ribosomal protein genes are enriched in inactive RNA
pol II
We measured the association of RNA pol II with yeast genes in
exponentially grown cells in YPD by performing RNA pol II ChIP-
on-chip experiments (RPCC, Pelechano et al., to be published
elsewhere). All normalized and processed genomic data are
included in Table S1. We compared the Rpb1-binding data
obtained by RPCC with the transcription rate (TR) data previously
measured by GRO [29]. We found that the ribosomal protein genes
(RP regulon) were relatively enriched in Rpb1 (using a Myc-tagged
version ofit,seeFigureS1). Even clearer resultswereobtained when
the RPCC experiments were performed with the 8WG16 antibody,
which recognizes RNA pol II CTD (Figure 1A). Gene classes
relating to cytosolic ribosome and translation presented significantly
high ChIP/TR ratios (Table 1). A prominent RNA pol II
enrichment was also detected in RP genes with an antibody that
recognizes the CTD repeats when these are phosphorylated in the
serine residue situated at position 5 (Ser5) (Figure 1B and Table 1).
All statistically significant GO categories found in all the genomic
experiments are included in Table S2.
We reason that the difference between the GRO and the RPCC
data, reflected in the ChIP/TR ratios, could be due to the
different degree of accumulation of non-actively elongating RNA
pol II either in a step prior to initiation or arrested during
elongation (likely back-tracked). Our data indicate that the inactive
form of RNA pol II (not producing a run-on signal) which
accumulated in RP genes was phosphorylated in the Ser5 residue
of the CTD. Therefore, we conclude that it should have passed the
initiation step of transcription.
The accumulation of inactive RNA pol II on ribosome-
related genes is regulated in response to metabolic
changes
The detected imbalance between the amounts of RNA pol II
bound to RP genes and their TR may either be an intrinsic feature
of these genes or reflect the occurrence of a novel mechanism that
regulates their expression. In order to test these two possibilities,
we calculated the ChIP/TR ratios in three different culture
conditions: i) exponential growth in glucose medium, ii) 2 h after
transferring glucose-grown cells to galactose-containing medium
(non growing cells due to the metabolic shift), and iii) exponential
growth in galactose medium (14.5 h in galactose). Then we did a
clustering analysis to group genes in accordance with their ChIP/
TR patterns. As shown in Figure 2A, two clusters were detected
(numbers 0 and 3) in which the ChIP/TR ratio clearly decreased
during the shift from glucose to galactose (2 h), and continued to
decrease when cells grew exponentially in galactose (14.5 h). The
difference between these two clusters was the kinetics of the ChIP/
TR decrease, that is, more intense in the first step for cluster
number 0 and deeper in the second step for cluster number 3
(Figure 2A). The genes belonging to the RP and RiBi regulons
were significantly enriched in cluster 0, although RiBi genes were
also located in cluster 3 (Figure 2A). The RiBi regulon comprises
all the genes encoding the non RP proteins involved in rDNA
transcription, tRNA synthesis, ribosome biogenesis and translation
(see [30] for a more precise definition of RiBi). The opposite
scenario (higher ChIP/TR ratios in galactose than in glucose) was
detected for clusters 6 and 8, which were statistically enriched in
mitochondria-related genes. We detected a general genome-wide
correlation between the ChIP/TR ratios of cells exponentially
growing in glucose and those of cells exponentially growing in
galactose, indicating that the lower ChIP/TR ratios shown by the
RP and RiBi regulons in galactose and the higher ChIP/TR ratios
displayed by mitochondria-related genes indeed reflect a specific
regulatory phenomenon (Figure 2B and Table 1).
In the first step of the experiment (2 h), the TR and the amounts
of RNA pol II binding to most genes, including the RP regulon,
sharply decreased (Figure 2C). This reduction in the genome
Author Summary
Transcription of DNA–encoded information into RNA is the
first step in gene regulation. RNA polymerases initiate
transcription at the promoter region and elongate the
transcripts traveling throughout the gene until reaching
the termination sequences. Classical models of transcrip-
tional regulation were focused on the initiation step, but
there is increasing evidence for gene regulation after
initiation. We have investigated the importance of
elongation in gene regulation using the yeast Saccharo-
myces cerevisiae, one of the main experimental systems in
modern biology. By comparing the genomic distribution of
RNA polymerase molecules with the actual transcriptional
signal across the genome, we have detected that many
genes are regulated at the elongation level. We show that
yeast cells use this step to modulate the expression of
several groups of genes, which have to be simultaneously
regulated in a very coordinated manner. Genes encoding
essential functions, like those related to protein synthesis
and respiration, change their transcriptional activities in
response to environmental stimuli, without changing in
the same extension the amount of RNA polymerase that is
physically associated to them. We also show that this kind
of regulation, in spite of taking place during the
elongation step, can be mediated by promoter-binding
transcription factors.
Coordinated Control of Transcription Elongation
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growth after shifting the culture from glucose to galactose media.
Transcription increased in step two (14.5 h) once cells recovered
their exponential growth rate, as did the TR of the RP genes and
the amount of RNA pol II bound to them (Figure 2C). During
these successive down- and up-regulation steps however, the
ChIP/TR ratios of RP and RiBi genes continuously decreased in
relation to the genome average (Figure 2D; Figure S2A, S2B). This
was mainly due to a decrease in the relative amount of bound
RNA pol II (Figure S2C) rather than to a relative change in their
TR (Figure S2D). Mitochondria-related genes also underwent a
similar down- and up-regulation cycle in both their TR and the
levels of bound RNA pol II (Figure 2C), although the average
ChIP/TR ratios increased in this case (Figure 2D; Figure S2A,
Table 1. GO categories showing statistically significant enrichment in high or low ChIP/TR ratios, or in TR after Spt16 depletion, in
all the genomic experiments done.
Gene Ontology Experiment
zLog2
(ChIP
8WG16/
TR)
zLog2
(ChIP
Ser5P/
TR)
ChIP
RNApolII/
TR(14.5hYPGal/
YPD)
ChIP
RNApolII/TR
(2h YPGal/
YPD)
ChIP
RNApolII/TR
(2h YPGal/
14.5h YPGal)
ChIP
RNApolII/
TR (Dtpk1/
wt)
ChIP
RNApolII/
TR (Dtpk2/
wt)
ChIP
RNApolII/
TR(rap1
Dsil/RAP1)
Log2
(TR5h/
TRC)
Log2
(TR7h/
TRC)
structural constituent of ribosome
(GO:0003735)
36236 222 25 274 5
large ribosomal subunit (GO:0015934) 1 1 220 215 24 22 282 3
translation (GO:0006412) 4 227 216 28 26 253 4
ribosome biogenesis and assembly
(GO:0042254)
22 243 213 12 213 213 40 3
eukaryotic 48S initiation complex
(GO:0016283)
26221 252 26 22 271 9
cytosolic part (GO:0044445) 4 8 239 222 7 212 212 216 45 1
mitochondrial part (GO:0044429) 211 5 3 271 5 1 0 28 23
mitochondrion (GO:0005739) 16 2 2697 28
membrane (GO:0016020) 9 5 9 4 221 2 1 4 217 24
The data represent the 2log10 (adjusted p-value). The positive values represent categories with ratios higher than average, while the negative ones represent those
with lower than average ratios. In many cases, blanks represent categories (e.g. ribosome-related) that, although statistically significant when performing a supervised
analysis, do not pass the filter of adjusted p-value at 0.05 (FDR test).
doi:10.1371/journal.pgen.1000614.t001
Figure 1. RP genes exhibit higher levels of RNA pol II than expected from their transcription rates. The RP genes of cells exponentially
growing in glucose-containing medium are enriched in RNA pol II, as compared to their transcription rates (TR). The levels of RNA pol II were
measured by ChIP-on-chip using either the 8WG16 antibody recognizing the RNA pol II CTD (A), or an antibody that specifically recognizes the Ser5-
phosphorylated form of Rpb1-CTD (B). The text insert describes the average values for the mean with a confidence interval of 95%, assuming a
Gaussian distribution and using the standard error of the sample mean.
doi:10.1371/journal.pgen.1000614.g001
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PLoS Genetics | www.plosgenetics.org 3 August 2009 | Volume 5 | Issue 8 | e1000614Figure 2. The proportion of active RNA pol II present in RP, RiBi, and mitochondria-related genes is regulated upon the carbon
source shift and depends on PKA. (A) K-means clustering analysis of the ChIP/TR profiles of cells exponentially growing in glucose medium (point
1), not growing after shifting to galactose for 2 h (point 2) and exponentially growing in galactose after 14.5 h in this medium (point 3). Graphs
represent the 9 clusters (0 to 8) obtained, showing the three-point profiles of the z-scores of the ChIP/TR ratios in log2 scale for the group’s genes
(shaded gray lines) and the average profile line in black. Overrepresented functional gene categories are indicated below together with the p-value of
the hypergeometric test of statistical significance. The number of genes present in each cluster is also given. (B) The proportion of active RNA pol II
present in both the RP (blue triangles) and the RiBi (red dots) genes is lower in glucose than in galactose. Mitochondria-related genes (orange
diamonds) show the opposite pattern. (C) Variation in RNA pol II levels (ChIP with 8WG16) and TRs for RP (blue panels) and mitochondria-related
(orange panels) genes under the three conditions described in (A). The error bars show the standard error of the sample mean. Black lines indicate the
genome average. (D) Change of ChIP/TR ratios, normalized in relation to the genome average, for the RP, RiBi and mitochondria-related genes during
the glucose-galactose shift. The profile shown is equivalent to those shown in part (A) but with the average value for only the functional categories
described. The standard error of the sample mean bars are shown. (E, F) The Dtpk1 and Dtpk2 mutations mimic the effect of galactose on the ChIP/TR
ratios. The proportion of active RNA pol II present is lower for the RP and RiBi genes, and is higher for mitochondria-related genes in tpk mutants than
in the wild type. In all these experiments, RPCC was performed using the 8WG16 antibody. Text inserts are as in Figure 1. All ChIPs were normalized to
a non-transcribed region (chromosome V, intergenic region V).
doi:10.1371/journal.pgen.1000614.g002
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genes was also due to a change in the relative amount of bound
RNA pol II (Figure S2C) rather than to a variation in the relative
TR of respiration genes (Figure S2D). We conclude that the shift
from glucose to galactose, and not the growth rate, was the
stimulus responsible for the ChIP/TR regulation of RP, RiBi and
mitochondria-related genes.
The transcriptional response of RP genes to glucose levels is
mediated by the TOR and Ras-PKA pathways [31]. To further
confirm that glucose signaling regulates the ChIP/TR ratios of
ribosomal related genes, we analyzed a Dtpk1 mutant. Tpk1 is one
of the three PKAs present in yeast and it is physically located on
those genes which are highly transcribed [32]. As shown in
Figure 2E, the ChIP/TR ratio of RP and RiBi genes lowered,
while the mitochondrial genes increased in the Dtpk1 when
compared to an isogenic wild type grown in YPD. The results of
Dtpk1 resembled those of the wild type in galactose (compare
Figure 2B and 2E).
Tpk2 is a second PKA catalytic subunit which is physically
located on the promoter regions of RP genes [32]. The results of
analyzing a Dtpk2 mutant showed similar patterns to those
observed in Dtpk1. We did not observe any significant variation
in the ChIP/TR ratios of RP genes between Dtpk1 and Dtpk2.W e
conclude that PKA mediates the signal which regulates the ChIP/
TR ratios of RP, RiBi and mitochondrial genes in response to the
glucose-galactose shift, but its participation in this regulation does
not depend on a particular catalytic subunit.
Genes encoding ribosomal proteins are enriched in Spt16
The chromatin elongation factor FACT is formed in yeast by
Spt16, Pob3 and Nhp6 [33]. It has been shown that FACT is
physically located on active yeast genes along the whole length of
their transcription units [34]. In order to test whether the
accumulation of inactive RNA pol II on RP genes in glucose is
extensive to transcription elongation factors, we measured the
amount of Spt16 bound to yeast genes by performing ChIP and
by hybridizing the same kind of arrays as we used for GRO and
RPCC experiments. As Figure 3A depicts, there is a general
positive correlation between the amount of Spt16 bound to a
gene and its TR (see also Figure S3A), and similarly to RNA pol
II, the RP genes show higher levels of Spt16 than those expected
for their TR (Figure 3A and Figure S3B). In contrast, the RP
genes showed no Spt16 enrichment in relation to the amount of
RNA pol II bound to them (Figure 3B). Irrespectively of the TR,
we found a close correlation between RNA Pol II and Spt16
levels of occupancy, as well as a constant Spt16/Rpb1 ratio
(Figure S3C), which suggests that the presence of RNA pol II on a
gene, rather than its transcriptional activity, causes FACT
recruitment.
By using a Tet-off::SPT16 strain, we have previously shown that
there is some gene-specificity in the effect of Spt16 depletion on
yeast transcription [28]. In order to test whether the excess FACT
present in RP genes was dispensable for their actual transcription
rates in glucose, we analyzed the transcriptional effect of Spt16-
depletion on a genome-wide scale. Following the GRO procedure,
we were able to calculate the effect of Spt16 depletion on TR of
5257 genes, which represents 91% of the genes present in the yeast
genome. We took these measurements at depletion times at which
neither the growth rate nor the viability of the cells was affected.
Five hours after adding doxycycline the overall mRNA levels in the
cell were not affected (Figure S4A) but the TR of most genes had
decreased (Figure 3C and Figure S4B), which is in agreement with
the general positive roles played by FACT in transcription [35,36].
By carrying out a gene-ontology analysis of the TR decrease, we
detected functional classes of genes that were particularly sensitive
or insensitive to Spt16 depletion. We found that the RP and RiBi
regulons were especially resistant to Spt16 depletion (Figure 3C
and Table 1), whereas those genes related to the mitochondria
were ranked as hypersensitive (Table 1). Since ribosomal proteins
genes are generally short and contain introns, we analyzed the
influence of several structural gene features on sensitivity to Spt16
depletion. No correlation with gene length, G+C content or intron
presence was found (Figure S5A, S5B, S5C). Since RP genes are
highly transcribed, we also checked the influence of TR itself on
the response to Spt16 depletion. We found a linear correlation
between TR under depletion conditions and control conditions,
thus ruling out that highly expressed genes were proportionally less
sensitive to Spt16 depletion (Figure S5D).
We performed additional GRO experiments with doxycycline-
treated cells over a longer time to achieve a more severe depletion
of Spt16. As shown in Figure 3C, the RP regulon showed a similar
distribution of TR to the rest of the genome after 7 h of treatment
with doxycycline. At this depletion time almost no overrepresen-
tation of gene ontology classes was observed (Table 1). These
results confirm that the slight accumulation of FACT on the RP
and RiBi regulons, in relation to the levels of actively elongating
RNA pol II present, makes these genes transiently resistant to
Spt16 depletion. Collectively, these results suggest that not only
RNA pol II, but additional elements of the transcription
elongation machinery, are enriched on the ribosome-related genes
in glucose, if compared to their TR.
Inactive RNA pol II accumulates in glucose in the body of
RP genes
The exceeding signal of RPCC over GRO in glucose for RP
genes suggests that an accumulation of non-transcribing RNA
polymerases takes place. The accumulation of inactive RNA pol II
on ribosome-related genes is compatible with a post-recruitment
mechanism of transcription regulation. With paused metazoan
genes, the intragenic distribution of RNA pol II is biased toward
the 59 end. In order to know whether the RNA pol II enrichment
of RP genes also involves a biased distribution of the enzyme, we
analyzed in detail the distribution of RNA pol II on a
representative RP gene (RPS3) by ChIP (Figure 4A–4D). As
expected, we found higher levels of total RNA pol II in glucose
than in galactose (Figure 4B), but we observed lower levels of Ser5-
, and much lower levels of Ser2-phosphorylated RNA pol II in
glucose on the 39 end of the transcribed region (Figure 4B). These
different intragenic distributions of RNA pol II are fully
compatible with a lower elongation efficiency of RNA pol II in
glucose in relation to galactose. The representation of the data
following the normalization procedure described by [37] supports
this conclusion (Figure 4C). Likewise, the representation of the
levels of phosphorylated RNA pol II, normalized by the total levels
of the enzyme, reveals a clear difference between the two
conditions. Whereas phosphorylation in galactose followed the
standard pattern, with a moderate decrease of Ser5-phosphoryla-
tion along the gene and a sharp increase of Ser2-phosphorylation
towards the 39 end, the increase of Ser2-phosphorylation in
glucose along the gene was considerably less evident (Figure 4D).
Very similar results were obtained with the detailed analysis of the
gene encoding ribosomal protein L25 (Figure S6A, S6B, S6C,
S6D).
We also investigated the intragenic distribution of active RNA
pol II by performing a detailed run-on analysis of the RPS3 gene.
In this case, we found similar patterns in both glucose and
galactose with comparable levels on the 39 and medium regions of
Coordinated Control of Transcription Elongation
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gene in galactose than in glucose (Figure 4E). These results support
the hypothesis that the accumulation of RNA pol II on RP genes
in glucose took place during elongation and was due to a
transcriptionally inactive form of RNA pol II that lacked normal
levels of Ser2 phosphorylation.
In order to confirm the variation in the intragenic distribution of
RNA pol II in RP genes from glucose to galactose, we repeated the
RPCC experiments described before with a new type of DNA
macroarrays containing 300 bp-long probes covering separately
the 59 and the 39 ends of the transcribed regions of a set of
randomly chosen genes (Rodrı ´guez-Gil et al, submitted). We found
that most of the RP genes present in this array presented a higher
RPCC 59/39 ratio in glucose than in galactose (Figure 4F and 4G).
This seems to be specific for RP genes since the RiBi genes
represented in the array showed similar RPCC 59/39 ratios in the
two media, as most non ribosomal genes did (Figure 4F and 4G).
We also discovered that neither RP nor RiBi genes showed
significantly higher GRO 59/39 ratios in glucose than in galactose,
thus confirming that the enrichment of RNA pol II located toward
the 59 end of RP genes in glucose consisted of transcriptionally
inactive molecules (Figure S6E).
Figure 3. RP genes are enriched in FACT in relation to their transcription rates, but FACT levels correlate with RNA pol II. (A) RP genes
present higher Spt16-Myc levels, as measured by ChIP-on-chip, than expected from their TRs. The dashed bisector line indicates the ratio 1. (B) No
enrichment of Spt16 on the RP genes, in relation to the Rpb1-Myc levels, was measured by ChIP-on-chip. (C) The transcription rates (TR) of the total
(upper panel) and RP (lower panel) genes, measured by genomic run-on, are transiently resistant to Spt16 depletion at 5 h, but not at 7 h. TRs are
given as the ratios to the corresponding ones after 5 h of mock treatment. Text inserts are as in Figure 1.
doi:10.1371/journal.pgen.1000614.g003
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PLoS Genetics | www.plosgenetics.org 6 August 2009 | Volume 5 | Issue 8 | e1000614Figure 4. Intragenic distribution of different forms of RNA pol II in RP genes. (A) The amplicons/probes used for RNA pol II ChIP and run-on
analyses of RPS3. (B) ChIP distribution of total RNA pol II (upper panels) and its phosphorylated CTD forms, in Ser5 (second-line panels) and Ser2
(third-line panels) in cells exponentially growing in glucose (blue bars) or galactose (red bars). The averages of four experiments are shown. Error bars
represent the standard deviation. (C) Profile of intragenic RNA pol II distribution in RPS3 in glucose in relation to its distribution in galactose and to
the levels of RNA pol II present in the promoter region. Data are relative to probe 2 because the probe 1 data are very low, producing high error levels
in relative calculations (not shown). (D) The relative distribution of phosphorylated forms of RNA pol II CTD with regard to the total amount measured
by ChIP. Note the lower relative levels of phosphorylated forms in glucose and the opposing behaviors along the gene of the Ser2 and Ser5
phosphorylated forms in galactose. (E) Run-on distribution in cells exponentially growing in glucose (blue bars) or galactose (red bars). The averages
of two experiments are shown. Results were normalized according to the signal of the probes of PRI2 present on the same filters, as described in
Materials and Methods. Error bars represent the standard deviation. (F) The intragenic distribution of RNA pol II in RP genes, measured by ChIP-on-
chip using an array of 59 and 39 probes of 231 highly expressed genes, is biased toward the 59 end of the coding region in glucose in relation to the
distribution in galactose. (G) Unlike the RP genes, the RiBi genes show almost the same glucose/galactose pattern as the RNA pol II intragenic
distribution as the other non RP genes present in the array. Text inserts are as in Figure 1.
doi:10.1371/journal.pgen.1000614.g004
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recruitment regulation of RNA pol II transcription in RP
genes
So far we have described a novel regulated phenomenon
affecting the RP genes expression. It is expected that the
mechanism underlying it would be operated by the transcription
factors that specifically regulate these genes. A transcription factor
playing a mayor role in RP genes transcription is Rap1, a
multifunctional protein that also acts as the main duplex DNA
binding protein at telomeres, which not only contributes to
silencing in both the subtelomeric regions and the mating type loci,
but also activates the transcription of glycolytic genes (reviewed by
[38,39]). Rap1 is essential for the RP expression as it organizes
chromatin configuration at the RP genes promoters and allows the
binding of Fhl1-Ifh1, that is, the other two main transcription
factors regulating the transcription of RP genes [40]. An important
domain of Rap1 is its silencing domain, which is involved in the
subtelomeric recruitment of factors that regulate telomere length
and gene silencing [41]. Since mutants lacking the silencing
domain of Rap1 are viable and do not show reduced levels of RP
gene expression [42], we decided to measure the influence of this
mutation on the level of RNA pol II bound to RP genes and on
their TR. As shown in Figure 5A, RP were the most enriched
genes in RNA pol II in both the wild-type and the rap1Dsil mutant.
However, and importantly, they were more transcribed in rap1Dsil
than in the wild type (Figure 5B). Consequently, RP genes
displayed a significantly low ChIP/TR ratio in the rap1Dsil mutant
(Figure 5C). As expected, mitochondria-related genes were
unaffected by rap1Dsil mutation (Figure S7). The ChIP/TR ratios
of RiBi genes, most of which are not directly regulated by Rap1,
did not undergo mayor change either (Figure S7C). In this case,
they displayed slightly higher levels of both RNA pol II binding
and transcriptional activity (Figure S7A, S7B), which probably
reflect their upregulation in response to the overexpression of RP
genes caused by rap1Dsil. As expected, rap1Dsil mutation also led to
an increase in the TR of subtelomeric genes, but not in RNA pol II
binding (Figure S8).
We also investigated the distribution of RNA pol II along RPS3
in the rap1Dsil mutant. We found no clear difference in the
intragenic distribution of bound RNA pol II when compared to
the wild type (Figure 5D). However, we detected higher levels of
active RNA pol II in the mutant measured by run-on, throughout
the transcribed region (Figure 5E). Similar results were found for
RPL25 (Figure S9A, S9B). We conclude that the silencing domain
of Rap1 participates in the mechanism which controls the
proportion of RNA Pol II that is effectively active on RP genes
during transcription elongation.
Discussion
The proportion of recruited RNA pol II machinery that is
transcriptionally active is gene-specific
In this work, we show that the transcriptionally active
proportion of RNA pol II bound across the genome is gene-
specific and can be regulated in response to physiological stimuli.
The presence of glucose causes an accumulation of inactive RNA
pol II on RP genes. FACT, a general chromatin factor that is
recruited to transcribed genes, also presents an uneven distribu-
tion, similar to that shown by RNA pol II. This indicates that not
only RNA pol II accumulates on some genes, but other
components of the transcriptional machinery that follow this
enzyme during elongation also do. Conversely, the presence of
galactose, or more likely, the absence of glucose, leads to a
decrease in the proportion of inactive RNA pol II on RP and RiBi
regulons, and increases it on mitochondria-related genes. Briefly, a
set of at least 1000 genes (more than 15% of the yeast genome)
coordinately changes the fraction of RNA pol II that is effectively
active during their transcription.
Genome-wide analysis has shown that TOR and PKA pathways
co-regulate several gene regulons in yeast, including RiBi, RP and
respiration-related genes [31]. Whereas TOR acts as an activator
of all three regulons, the PKA pathway acts by repressing
respiratory genes and by activating the RP and RiBi genes. Here
we show that the absence of either Tpk1 or Tpk2, two of the yeast
PKA variants, produces the same kind of changes in the ChIP/TR
ratios on RP, RiBi and mitochondria-related genes as the
changing growth of the wild type from glucose to galactose. This
indicates that the overabundance of inactive RNA polymerases is
characteristic of some specific groups of genes, under particular
growth conditions, and that it is regulated by the PKA pathway.
The fact that there is no difference between the lack of Tpk2, a
PKA subunit shown to be bound to RP genes promoters [32] and
Tpk1, a subunit bound to the body of most genes suggests that the
effect is quantitative: a reduction in PKA activity caused either by
the lack of the alternative subunits or the growth in galactose
reduces the accumulation of inactive RNA pol II molecules on
several kinds of yeast genes.
The importance of gene-specific regulation during elongation
across metazoan genomes can be deduced from the occurrence of
RNA pol II pausing, which is a frequent phenomenon mainly
affecting tightly regulated genes [3–7]. Our work indicates that the
control of RNA pol II elongation is also a common regulatory
mechanism in yeast. Unlike metazoan genes however, whose
paused RNA pol II concentrate at specific promoter-proximal
sites, elongation-regulated yeast genes, at least RPS3 and RPL25,
accumulate inactive RNA pol II along the length of their bodies
with only some bias toward their 59 moiety. This accumulation
correlates with a decrease in Ser2-phosphorylated RNA pol II
along these genes.
Transcription of ribosomal genes is regulated during
elongation
The experimental evidence described in this work reveals that an
excess of RNA pol II, phosphorylated in Ser5, accumulates on the
yeast RP genes in glucose. This situation is only compatible with a
post-initiation form of RNA pol II. However, the absence of a
comparably high run-on signal indicates that this extra amount of
RNA pol II, which accumulates in glucose media, should be arrested
after backtracking. A similar situation occurs in the Drosophila hsp70
gene upon depleting the TFIIS cleavage factor [43].
Regulation of ribosome synthesis is a key element in controlling
cell homeostasis, cell size and proliferation [30]. A coordinated
and balanced expression of all the ribosomal protein genes is also
needed to ensure efficient ribosome assembly [44], and to avoid
the potential toxicity of free ribosomal proteins [45]. Regulation at
the transcription elongation level may provide a gear box-like
mechanism which enables a fine-tuning of RP and RiBi
transcription by rapidly adjusting the proportion of recruited
machinery that is effectively active in response to the specific
translational requirements of each physiological state. According
to a recently proposed model, a certain level of backtracking
during elongation, in combination with a fast initiation step,
provides a steadier mRNA population level than that which would
be produced by an initiation model alone [46]. Accordingly, the
regulation of RP transcription elongation would allow the
expression of balanced amounts of translational machinery
components. It would also contribute to avoid transcription bursts,
which would be incompatible with the low transcriptional noise
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PLoS Genetics | www.plosgenetics.org 8 August 2009 | Volume 5 | Issue 8 | e1000614Figure 5. Ablation of the Rap1 silencing domain increases the proportion of active RNA pol II on RP genes. (A) RNA pol II levels, as
detected with the 8WG16 antibody, on the RP genes are not significantly affected by the rap1Dsil mutation. (B) The rap1Dsil mutation increases the
levels of active RNA pol II, as detected by run-on, on RP genes. (C) The proportion of active vs. total RNA pol II on the RP genes is significantly lower in
the rap1-Dsil mutant than in the wild type (RAP1). (D) Although there is no significant difference in the distribution of total RNA pol II molecules
within the RPS3 gene, there is a significant increase (E) of the active RNA pol II molecules toward the 39 end of this gene in the rap1-Dsil mutant in
relation to the wild type. Run-on data were normalized according to the signal of the probes of PRI2 present on the same filters, as described in
Materials and Methods. The data shown in the histograms correspond to the average of two experiments. Error bars represent standard deviation.
Text inserts are as in Figure 1.
doi:10.1371/journal.pgen.1000614.g005
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specifically, the RP expression [48]. In addition, and as suggested
for Drosophila genes [5], regulating the transcription at the
elongation level enables a continuously open promoter configura-
tion, an essential situation for genes like RP which are being
permanently transcribed.
A feedback regulation mechanism operating at the intron
splicing level has been demonstrated for certain RP genes [49].
Since exon definition takes place during transcription elongation,
an attractive hypothesis would be the existence of coordination
between transcription elongation and RNA splicing in RP genes
[50]. However, our data do not support such a hypothesis since
RNA pol II enrichment, compared to TR, was detected in both
intron-containing and intron-less RP genes (data not shown).
RP and RiBi regulons show different RNA pol II- and FACT-
ChIP/TR ratios, which suggest that their regulation mechanisms are
not identical. We have also detected this kind of regulation in the
group of mitochondria-related genes, thus confirming the previously
described control of CYC1 transcription after RNApol II recruitment
[11,51]. In this case, the ChIP/TR ratios were reciprocal to those of
RP genes. If we consider this diversity, it is likely that at least one
subset of the molecular elements regulating the proportion of active
RNA pol II during elongation is gene-specific.
Rap1 regulates transcription elongation
We provide evidence for the specific involvement of the
silencing domain of Rap1 in the mechanism required to maintain
significant levels of inactive RNA Pol II on RP genes. We also
show that the absence of either Tpk1 or Tpk2 produces the same
phenotype on RP transcription. These results indicate that the
proportion of inactive RNA pol II on RP genes is controlled by the
factors that specifically regulate the transcription of RP genes. In
such a scenario, Rap1 would regulate the transcription of RP
genes at both the RNA pol II recruitment and transcription
elongation levels (Figure 6).
Tethering experiments using lexA-Rap1 chimeras have shown
that the Rap1 DNA-binding domain itself is required for the
activating function of Rap1 in RP transcription [40]. This
observation, together with the ability of Rap1 to clear nucleosomes
from the vicinity of its binding sites [52], suggests that the positive
contribution of Rap1 to RP transcription is exerted in a pre-
initiation step. This is likely to be done by arranging a chromatin
configuration of the promoter to allow the hosting of other RP
transactivators like Fhl1-Ifh1 [40] and, eventually, the pre-
initiation complex itself. The persistent occupancy of Rap1 on
RP promoters, even under transcriptionally inactive conditions
(stress), suggests that this factor may also play a repressive role
[53]. We provide evidence of a negative role of Rap1 on RP
transcription elongation which is mediated by its silencing domain.
This domain, located in the C-terminal part of the protein, has
been previously shown to be important for the downregulation of
RP transcription in response to certain defects in the secretory
pathway [54,55]. Graham et al. [42] showed that it also affects the
mRNA steady-state levels of RP genes. They attributed this effect
to the secondary post-transcriptional consequences of the rap1Dsil
deletions. Our results indicate that it is in fact a transcriptional
effect since the silencing domain has a negative influence on the
TR of both subtelomeric (Figure S8) and RP genes (Figure 5)
without affecting RNA pol II recruitment.
In Drosophila cells, hundreds of genes show that RNA
polymerase II molecules paused after initiation (about 20–50 bp
from the TSS), which has been argued to deal with the presence of
an H2AZ-containing positioned nucleosome [56]. In yeast, the
advanced position of the first nucleosome, overlapping the TSS
[15], makes such a mechanism unlikely. However and as we show
herein, the regulation of the chromatin configuration by DNA-
binding proteins like Rap1 may also have an effect on elongation.
The Rap1-dependent control that we propose for RP genes
should not be the only one acting at the elongation level across the
yeast genome as we have shown that at least two other functional
groups of genes, RiBi and mitochondria-related genes, display a
regulated variation in the proportion of active RNA polymerases.
This variation is controlled by PKA, but does not depend on the
silencing domain of Rap1. It is tentative to hypothesize that the
PKA pathway regulates a plethora of genes during the elongation
step of transcription by using different chromatin-related factors.
Materials and Methods
Yeast strains, growth conditions, and FACT depletion
The yeast strains used in this work are described in Table S3.
Cells were grown in YPD (yeast extract 1%, peptone 2%, glucose
2%) with agitation at 28uC, at OD600=0.5. In the experiment
done in the galactose medium, cells were harvested and changed
to YPGal (yeast extract 1%, peptone 2%, galactose 2%) and grown
for 2 h (lag phase) and 14.5 h (exponential growth).
For the SPT16 shut-off experiments, 5 mg/ml doxycycline was
added to exponentially growing SJY6 cells (OD600=0.1). Since the
experiments in this work were performed in rich media (YPD),
shorter times of incubation with doxycycline were required to
reach the same level of Spt16 depletion described in [28]. Control
cells were harvested after 5 hours of mock treatment.
Genomic run-on
Genomic run-on (GRO) was done essentially as described in
[29]. See supplementary materials and methods in Text S1.
Small-scale run-on for selected genes
To determine the intragenic distribution of elongating RNA pol
II molecules, we used macroarrays containing 300 bp probes from
the 59 and 39 ends of the coding regions of 377 yeast genes. These
59-39 macroarrays were manufactured by printing PCR products
onto a nylon Hybond N+ membrane, similarly to that described
for whole genome ORF macroarrays [57]. PCR products were
obtained by using either yeast genomic DNA as a template and the
primer pairs listed in Table S4, or a plasmid containing the ORF,
a common primer corresponding to the plasmid (YGUF for 59
probes or YGUR for 39 probes), and a specific primer
corresponding to the ORF, listed in Table S5, following the
procedure described in [57].
The run-on analysis of RPS3 and RPL25 was done as in GRO
experiments, but using miniarrays on nylon Hybond N+
membranes. These miniarrays were done by printing the PCR
products as described above using the amplicons listed in Table
S6. Probes of PRI2, a gene whose run-on levels were not
influenced by any of the elements tested in the GRO experiments,
were included for normalization.
Chromatin immunoprecipitation of RNA pol II and RPCC
A detailed protocol of RPCC will be published elsewhere
(Pelechano and Pe ´rez-Ortı ´n, submitted). A preliminary description
of it is included in the supplementary materials and methods (Text S1).
ChIP experiments of selected genes were performed as
previously described [28] with minor modifications. Shortly,
50 ml of yeast culture were collected at O.D. 0.5. Crosslinking
was performed by adding 1% Formaldehyde to the culture and
incubating at room temperature for 15 min. 2.5 ml of glycine was
then added and culture was incubated 5 min. Cells were then
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Saline at 4uC. The cell breakage was performed in 300 ml of lysis
buffer (see the above reference) with glass beads, and the cell
extracts were sonicated in a Bioruptor sonicator (Diagenode) for
30 min in 30 sec on/30 sec off cycles (chromatin was sheared into
an average size of 300 bp). Immunoprecipitation was performed
with magnetic beads, which were coated with protein A (Dynal)
and incubated with 8WG16 monoclonal antibody (Bavco
Covance), anti Ser2-P-CTD or anti-Ser5-P-CTD (kindly provided
by David Bentley) beforehand.
qPCR were performed to quantify immunoprecitation, using a
1:1500 dilution for the input samples or a 1:10 dilution for the
immunoprecipitated samples. Immunoprecipitation was defined as
the ratio of each probe specific product in relation to that of a non-
transcribed region (chromosome V, intergenic region V). Primers
used are listed in Table S6.
In silico functional analyses
All the experiments were done in triplicate except for the tpk2
mutant that was analyzed in duplicate. All the group functional
enrichment analyses were done using the Fatiscan application
from Babelomics [58]. The clustering of Figure 2A was done using
a k-means algorithm and the STEM program [59].
Accession numbers
Genomic data are stored in the Valencia Yeast (VYdBase;
http://vydbase.uv.es/) and GEO databases. The GEO accession
number for the set of hybridizations is GSE14084.
Supporting Information
Figure S1 RP genes are enriched in Rpb1 relative to their TR.
(A) Rpb1-Myc levels, measured by ChIP-on-chip using an anti-
Myc antibody, correlate with TR, measured by GRO. The RP
genes are enriched in Rpb1-Myc, in relation to their TR. (B) The
RP ChIP/TR ratios distribution (blue bars) is displaced toward
higher values compared to the overall genome distribution
(Gaussian line). Other symbols and the text insert are as in
Figure 1.
Found at: doi: 10.1371/journal.pgen.1000614.s001 (0.46 MB TIF)
Figure S2 RP, RiBi, and respiratory genes show specific changes
in the levels of RNA pol II present and in the proportion of active
RNA pol II, upon the carbon source shift. The proportion of RNA
pol II that is active on RP and RiBi, reflected inversely by the
ChIP/TR ratio, increases when cells are shifted from glucose
(YPD) to galactose medium (YPGal) for two hours (A) and
continues increasing when cultivated further in galactose medium
for 14.5 hours (B). Mitochondria-related genes show the opposite
pattern. The relative levels of RNA pol II on RP and RiBi genes
are lower in galactose than in glucose, whereas they are higher in
glucose than in galactose for mitochondria-related genes (C). The
relative distribution of all three groups of genes with regard to the
overall population in TR values do not change when comparing
cells exponentially growing in glucose and in galactose (D).
Symbols are as in Figure 1 and Figure 2.
Found at: doi: 10.1371/journal.pgen.1000614.s002 (1.50 MB TIF)
Figure S3 Correspondence between the presence of Spt16 and
Rpb1 and the observed TR. (A) Spt16-Myc and Rpb1-Myc,
measured by ChIP-on-chip, show a similar correlation with TR as
measured by GRO. A smoothness of the data, using 100 genes
sliding windows, is represented. As expected, NA (no antibody)
does not correlate with TR. (B) The distribution of the Spt16-
ChIP/TR ratios for the RP genes (blue bars) is displaced toward
higher values, in relation to the overall genome distribution
(Gaussian line). (C) The Spt16/Rpb1 ratio does not depend on the
transcription rate (TR). The RP genes (blue triangles) show the
same average Spt16/Rpb1 ratio as the rest of the genome.
Found at: doi: 10.1371/journal.pgen.1000614.s003 (0.80 MB TIF)
Figure S4 Effects of FACT (Spt16) depletion on yeast
transcription. (A) Overall levels of mRNA amounts and TRs
during Spt16 depletion. mRNA amounts were calculated as
Figure 6. Model for the regulation of transcription elongation in RP genes. Glucose stimulates RNA pol II recruitment to the RP genes by
means of the cAMP-PKA pathway. FACT would be recruited to the RP genes together with RNA pol II. PKA would also inhibit transcription elongation.
These two actions would be mediated by the DNA-binding RP-specific transcription factor Rap1, whose silencing domain is responsible for the
elongation-inhibitory function. Inhibition of elongation would favor RNA pol II backtracking, leading to an increase in the proportion of inactive
polymerases on the body of RP genes. RNA pol II molecules are shown in different colors and shapes according to their activity state: initiating or
actively elongating (pink) and backtracked (red).
doi:10.1371/journal.pgen.1000614.g006
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corresponding to the RNA pol II-dependent genes present in the
arrays, as described in M&M. Both were normalized to time 0. (B)
Overall distribution of TRs before and after Spt16 depletion.
Found at: doi: 10.1371/journal.pgen.1000614.s004 (0.46 MB TIF)
Figure S5 The changes in TR upon Spt16 depletion do not
correlate with the ORF length, G+C content, intron presence or
absolute TR. (A) No indication of the dependence of the TR
decrease on the gene length after 5 or 7 hours of depletion was
observed. Individual genes are shown as gray dots and the
tendency line for the sliding mean is shown as a red line. (B) G+C
content does not influence TR sensitivity to Spt16 depletion. (C)
The presence of introns does not preclude the sensitivity of TR to
Spt16 depletion. Among intron-containing genes, only RP show
resistance to Spt16 depletion at 5 h after doxycycline addition. (D)
After 5 or 7 h of Spt16 depletion, the linear relationship with the
control TR shows that absolute TR has no influence on the
transcriptional effect of Spt16 depletion.
Found at: doi: 10.1371/journal.pgen.1000614.s005 (1.03 MB TIF)
Figure S6 Intragenic distribution of different forms of RNA pol
II in RPL25 gene. (A) Amplicons/probes used for RNA pol II
ChIP and run-on analyses of RPL25. (B) ChIP distribution of total
RNA pol II (upper panels) and its phosphorylated CTD forms, in
Ser5 (second line panels) and Ser2 (third line panels) in cells
exponentially growing in glucose (blue bars) or galactose (red bars).
(C) Profile of intragenic RNA pol II distribution in RPL25 in
glucose, in relation to its distribution in galactose and to the levels
of RNA pol II present in the promoter region. (D) Relative
distribution of phosphorylated forms of RNA pol II CTD relative
to the total amount measured by ChIP. (E) The intragenic
distribution of RNA pol II in RP genes, measured by run-on using
an array of 59 and 39 probes, is not biased toward the 59 end of the
coding region in glucose, relative to the distribution in galactose.
Symbols as in Figure 4.
Found at: doi: 10.1371/journal.pgen.1000614.s006 (0.48 MB TIF)
Figure S7 Effect of rap1Dsil on the presence of RNA pol II in the
RiBi regulon and mitochondria-related genes. The rap1Dsil
mutation slightly increases the RNA pol II levels (A) and
transcription rates (B) in the RiBi genes (red dots) without affecting
their ChIP/TR ratios (C). No effect on either the RNA pol II
levels or transcription rates was detected in mitochondria-related
genes (orange diamonds).
Found at: doi: 10.1371/journal.pgen.1000614.s007 (1.17 MB TIF)
Figure S8 The rap1Dsil mutation increases the proportion of
active RNA pol II in subtelomeric genes. The rap1Dsil mutation
does not produce significant changes along the length of the
chromosome at the total RNA pol II levels, measured by ChIP-on-
chip (A, B). It does not produce an increase of active RNA pol
molecules along length of the the chromosome length either (C),
except within the 10 kb region near the telomeres (extended
resolution in D). The red and blue lines represent the averages of
the values using a sliding window of 50 genes. Horizontal lines
represent the upper and lower limit for this mean using a
Shewhart chart with a confidence range of 0.999.
Found at: doi: 10.1371/journal.pgen.1000614.s008 (1.22 MB TIF)
Figure S9 Effect of rap1Dsil on the presence and activity of RNA
pol II in RPL25. There is no significant difference in the
distribution of RNA pol II molecules within the RPL25 gene (A),
but there is a significant increase of active RNA pol II molecules
toward the 39 end of the gene in the rap1Dsil mutant with regard
to the wild type RAP1 (B).
Found at: doi: 10.1371/journal.pgen.1000614.s009 (0.10 MB TIF)
Table S1 Excel file containing all the normalized and processed
data.
Found at: doi: 10.1371/journal.pgen.1000614.s010 (5.92 MB
XLS)
Table S2 Excel file containing the statistically significant GO
categories found in all the genomic experiments.
Found at: doi: 10.1371/journal.pgen.1000614.s011 (3.49 MB
XLS)
Table S3 Yeast strains used in this work.
Found at: doi: 10.1371/journal.pgen.1000614.s012 (0.04 MB
DOC)
Table S4 Oligonucleotides used for the PCR amplification of
the first set of probes printed on the 59/39 arrays XLS.
Found at: doi: 10.1371/journal.pgen.1000614.s013 (0.11 MB
XLS)
Table S5 Oligonucleotides used for the PCR amplification of
the second set of probes printed on the 59/39 arrays.
Found at: doi: 10.1371/journal.pgen.1000614.s014 (0.05 MB
XLS)
Table S6 Oligonucleotides used for PCR amplification during
the detailed studies of RPL3 and RPL25.
Found at: doi: 10.1371/journal.pgen.1000614.s015 (0.01 MB
XLS)
Text S1 Supplementary Materials and Methods.
Found at: doi: 10.1371/journal.pgen.1000614.s016 (0.04 MB
DOC)
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